Literature DB >> 25078874

Relative adrenal insufficiency in chronic liver disease: its prevalence and effects on long-term mortality.

J Y Jang1, T Y Kim, J H Sohn, T H Lee, S W Jeong, E J Park, S H Lee, S G Kim, Y S Kim, H S Kim, B S Kim.   

Abstract

BACKGROUND: The relationship between relative adrenal insufficiency (RAI) and chronic liver disease is unclear. AIM: To determine the frequency with which RAI is observed in noncritically ill patients at various stages of chronic liver disease, and the correlation between RAI and disease severity and long-term mortality.
METHODS: In total, 71 non-critically ill patients with liver cirrhosis (n = 54) and chronic hepatitis (n = 17) were evaluated prospectively. A short stimulation test (SST) with 250 μg of corticotrophin was performed to detect RAI. RAI was defined as an increase in serum cortisol of <9 μg/dL in patients with a basal total cortisol of <35 μg/dL.
RESULTS: RAI was observed in only 13 (24.1%) of 54 patients with cirrhosis. Compared to those without RAI, cirrhotic patients with RAI had significantly higher Child-Turcotte-Pugh score (10.3 ± 1.7 vs. 7.1 ± 1.8, mean ± s.d., P < 0.001) and Model for End-Stage Liver Disease score (14.5 ± 6.6 vs. 9.4 ± 3.7, P = 0.017). The cortisol response to corticotropin was negatively correlated with the severity of cirrhosis (P < 0.05). In addition, the mortality rate was higher in cirrhotic patients with RAI (69.2%) than in those without RAI (4.9%; P < 0.001) during the follow-up period of 20.1 ± 13.5 months (range, 5.8-51.1 months). The cumulative 1-year survival rates in cirrhotic patients with and without RAI were 69.2% and 95.0%, respectively (P = 0.05), while the corresponding cumulative 3-year survival rates were 0% and 95.0% (P < 0.001).
CONCLUSIONS: Relative adrenal insufficiency is more commonly observed in those with severe cirrhosis, and is clearly associated with more advanced liver disease and a shortened long-term survival. This suggests that relative adrenal insufficiency is an independent prognostic factor in non-critically ill patients with cirrhosis.
© 2014 John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25078874     DOI: 10.1111/apt.12891

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  8 in total

Review 1.  Relative Adrenal Insufficiency in Patients with Cirrhosis: A Systematic Review and Meta-Analysis.

Authors:  Gaeun Kim; Ji Hye Huh; Kyong Joo Lee; Moon Young Kim; Kwang Yong Shim; Soon Koo Baik
Journal:  Dig Dis Sci       Date:  2017-02-07       Impact factor: 3.199

2.  ASSESSMENT OF ADRENOCORTICAL DYSFUNCTION IN PATIENTS WITH STABLE LIVER CIRRHOSIS.

Authors:  Ş Chiriac; C Stanciu; R Negru; A Trifan
Journal:  Acta Endocrinol (Buchar)       Date:  2016 Jul-Sep       Impact factor: 0.877

3.  Clinical characteristics and prevalence of adrenal insufficiency in hemodynamically stable patients with cirrhosis.

Authors:  Sang Hoon Park; Min Sun Joo; Byoung Hoon Kim; Ha Na Yoo; Sung Eun Kim; Jin Bae Kim; Myoung Kuk Jang; Dong Jun Kim; Myung Seok Lee
Journal:  Medicine (Baltimore)       Date:  2018-06       Impact factor: 1.889

4.  Cortisol in Peripheral Blood Predicts the Severity and Prognosis in Patients with Liver Failure at 90 Days.

Authors:  Jian Zhang; Junfeng Li; Mei Ding; Yu Chen; Zhongping Duan
Journal:  Risk Manag Healthc Policy       Date:  2021-10-16

5.  Pearls and pitfalls in nonalcoholic fatty liver disease: tricky results are common.

Authors:  Brian J Wentworth; Stephen H Caldwell
Journal:  Metab Target Organ Damage       Date:  2021-07-02

Review 6.  Adrenal Insufficiency in Cirrhosis.

Authors:  Brian J Wentworth; Helmy M Siragy
Journal:  J Endocr Soc       Date:  2022-07-29

Review 7.  Recent advances in the understanding and management of hepatorenal syndrome.

Authors:  Benedikt Simbrunner; Michael Trauner; Thomas Reiberger; Mattias Mandorfer
Journal:  Fac Rev       Date:  2021-05-21

8.  Prognostic Factors Related to the Mortality Rate of Acute-on-Chronic Liver Failure Patients.

Authors:  Jian Zhang; Junfeng Li; Yu Chen; Mei Ding; Zhongping Duan
Journal:  Diabetes Metab Syndr Obes       Date:  2021-06-09       Impact factor: 3.168

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.